The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines

The newly emerging variants of SARS-CoV-2 from India (Delta variant) and South America (Lambda variant) have led to a higher infection rate of either vaccinated or unvaccinated people. We found that sera from Pfizer-BioNTech vaccine remain high reactivity toward the receptor binding domain (RBD) of...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haolin, Wei, Pengcheng, Zhang, Qianqian, Aviszus, Katja, Linderberger, Jared, Yang, John, Liu, Junfeng, Chen, Zhongzhou, Waheed, Hassan, Reynoso, Lyndon, Downey, Gregory P., Frankel, Stephen K., Kappler, John, Marrack, Philippa, Zhang, Gongyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404886/
https://www.ncbi.nlm.nih.gov/pubmed/34462744
http://dx.doi.org/10.1101/2021.08.25.457692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404886/
https://www.ncbi.nlm.nih.gov/pubmed/34462744
http://dx.doi.org/10.1101/2021.08.25.457692

Ejemplares similares